SPOTLIGHT: FDA asks for data on asthma meds

The FDA has asked the makers of several beta agonist drugs for more data from clinical trials so it can "further evaluate the safety" of the drugs when used to treat asthma. Once the data is collected, the agency will convene an advisory panel to evaluate the safety risks. Back in 2005, FDA alerted healthcare professionals and patients that the drugs might increase the risk of worsened wheezing in some patients. Release

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.